Furaprevir

DB12785InvestigationalSmall molecule

Furaprevir is under investigation in clinical trial NCT01523990 (A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients).

Formula / weight: C₄₇H₅₆N₆O₁₀S · 897.06 g/mol (avg)
Code names: TG-2349

Resolves to

Compound

UNII0UMM44REU9CAS1435923-88-8PubChem51037069

Structure

InChIKeyGZRNOYTVBWWFLJ-NTPALUMKSA-NSMILES

CC(C)OC1=CC=C(C=C1)C1=NC2=C(OC3=C2C=CC=C3)C(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@H](CCCCC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)NC(=O)OC2CCCC2)=N1

Targets

P26664Genome polyprotein

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Furaprevir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account